
Johnson Fistel, PLLP is investigating whether Clorox's executives misled investors after the company reported a significant drop in gross margin and lowered its full-year outlook. Clorox revealed a 140 basis point margin decline and expects a 250-300 basis point drop for fiscal 2026, citing higher supply chain costs and delayed cost savings. The stock price fell sharply following these disclosures, prompting the investigation into potential securities law violations. Investors who suffered losses are encouraged to contact Johnson Fistel for possible recovery options.